发明名称 IMIDAZODIAZEPINES
摘要 <p>RAN 4008/324 The novel imidazodiazepines of the general formula wherein A together with the two carbon atoms denoted at .alpha. and .beta. signifies the group (a) or (b) R1 signifies hydrogen, lower alkyl, lower alkoxymethyl, halogen or nitro, R4 signifies hydrogen, trifluoromethyl or halogen, R5 signifies hydrogen, trifluoromethyl, halogen or lower alkyl and X signifies an oxygen or sulphur atom, and either R2 signifies hydrogen and R3 signifies lower alkyl or R2 and R3 together signify trimethylene or propenylene and the carbon atom denoted as y has the (S)or (R,S)-configuration, and their pharmaceutically acceptable acid addition salts antagonize the central-depressant, muscle relaxant, ataxic, blood pressure-lowering and respiratory-depressant properties of 1,4-benzodiazepines which have tranquillizing activity, and can be used, for example, as antidotes in the case of intoxications with 1,4-benzodiazepines which have tranquillizing activity, for shortening anaesthesia induced by such 1,4-benzodiazepines etc; they can also be used for suppressing the activities on the central nervous system of 1,4-benzodiazepines which are used in other fields of indication, for example of schistosomicidally -active 1,4-benzodiazepines such as (+)-5-(o-chlorophenyl)- -1,3-dihydro-3-methyl-7-nitro-2H-1,4-benzodiazepin-2-one. The compounds of formula I above can be manufactured according to various methods starting from partly novel starting materials and can be used in galenical administration forms.</p>
申请公布号 CA1174673(A) 申请公布日期 1984.09.18
申请号 CA19810392373 申请日期 1981.12.16
申请人 HOFFMANN-LA ROCHE LIMITED 发明人 HUNKELER, WALTER;KYBURZ, EMILIO
分类号 A61K31/55;A61P33/10;A61P39/02;A61P43/00;C07D243/14;C07D487/04;C07D487/14;C07D495/04;C07D495/14;C07D495/22;C07D498/04;(IPC1-7):C07D487/04 主分类号 A61K31/55
代理机构 代理人
主权项
地址